Most not long ago, it's been discovered that conolidine and the above derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in comparable regions as classical opioid receptors, it binds to a wide array of endogenous opioids. Compared with most opioid receptors, this receptor acts being a scavenger and won't activate a next messenge